Identifying Mitochondrial Transcription Factor A As a Potential Biomarker for the Carcinogenesis and Prognosis of Prostate Cancer
Open Access
- 1 January 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in Genetic Testing and Molecular Biomarkers
- Vol. 27 (1), 5-11
- https://doi.org/10.1089/gtmb.2022.0141
Abstract
Aims: Mitochondrial functional transformation contributes to the carcinogenesis of the prostate by meeting the metabolic needs of cancer cells. Mitochondrial transcription factor A (TFAM) is a pivotal regulator that maintains homeostasis of mitochondrial function. However, its role in prostate carcinogenesis has not been well elucidated. Materials and Methods: In the present study, we analyzed the expression of TFAM in normal prostate tissue and prostate cancer using public databases; a prostate-tissue chip was used to verify the results. The expression of TFAM in normal cells and in prostate cancer cells was determined by western blotting analysis. We knocked down TFAM in the prostate cancer cell line PC3 using a specific shRNA to explore the potential effects of TFAM in prostatic carcinogenesis. Results: We observed higher expression levels of TFAM in prostate cancer tissue than in normal prostate tissue and tumor adjacent normal tissues. A receiver operating characteristic curve was drawn that demonstrated the diagnostic efficacy of using TFAM expression for prostate cancer prognoses. Elevated levels of TFAM may indicate poorer overall survival in prostate cancer patients. Western blotting assays also showed that relative to the normal prostatic epithelial cell line RWPE-1, prostate cancer cell lines PC3 and DU145 expressed more TFAM protein. Furthermore, knockdown of TFAM inhibited the colony-formation capability of PC3 cells. Conclusion: Collectively, these results suggest that TFAM promotes carcinogenesis of the prostate, and may constitute a marker to be used in the diagnosis and prognosis of prostate cancer.Keywords
This publication has 22 references indexed in Scilit:
- MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM)Biomedicine & Pharmacotherapy, 2017
- Association of a TFAM haplotype with aggressive prostate cancer in overweight or obese Mexican Mestizo menUrologic Oncology, 2016
- Mitochondrial pathways to cardiac recovery: TFAMHeart Failure Reviews, 2016
- GPR30 Promotes Prostate Stromal Cell Activation via Suppression of ERα Expression and Its Downstream Signaling PathwayEndocrinology, 2016
- Mitochondrial DNA copy number variation across human cancerseLife, 2016
- Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergeticsOncotarget, 2016
- Mitochondrial Transcription Factor A Worsens the Clinical Course of Patients With Pancreatic Cancer Through Inhibition of Apoptosis of Cancer CellsPancreas, 2014
- Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy numberBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2012
- DNA Replication and Transcription in Mammalian MitochondriaAnnual Review of Biochemistry, 2007
- Mitochondrial transcription factor A is necessary for mtDNA maintance and embryogenesis in miceNature Genetics, 1998